These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Lymphovascular invasion as an independent predictor of recurrence and survival in node-negative bladder cancer remains to be proven. Reuter VE J Clin Oncol; 2005 Sep; 23(27):6450-1. PubMed ID: 16129842 [No Abstract] [Full Text] [Related]
8. Proceedings: management of late stage carcinoma of the bladder. Thomas H Br J Urol; 1975 Apr; 47(2):233. PubMed ID: 1148639 [No Abstract] [Full Text] [Related]
9. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience. Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803 [TBL] [Abstract][Full Text] [Related]
10. Re: Matthew E. Nielsen, Shahrokh F. Shariat, Pierre I. Karakiewicz et al. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur urol 2007;51:699-708. Cai T; Bartoletti R Eur Urol; 2007 Aug; 52(2):611-2. PubMed ID: 17400362 [No Abstract] [Full Text] [Related]
11. [Factors affecting the recurrence rate and progression of superficial (Ta-T1) bladder tumors]. Kondás J Orv Hetil; 1985 Mar; 126(10):577-80. PubMed ID: 3991152 [No Abstract] [Full Text] [Related]
12. [Testicular metastasis from transitional cell carcinoma of the bladder]. Negelev S; Paz A; Segal M Harefuah; 1995 Jan; 128(2):90-1, 127. PubMed ID: 7721183 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118 [TBL] [Abstract][Full Text] [Related]
14. Behavior of urothelial carcinoma with respect to anatomical location. Catto JW; Yates DR; Rehman I; Azzouzi AR; Patterson J; Sibony M; Cussenot O; Hamdy FC J Urol; 2007 May; 177(5):1715-20. PubMed ID: 17437794 [TBL] [Abstract][Full Text] [Related]
15. [Cystectomy or transurethral resection in the treatment of bladder carcinoma]. Flamm J; Kiesswetter H; Burkert S Z Urol Nephrol; 1982 Oct; 75(10):729-37. PubMed ID: 7158092 [TBL] [Abstract][Full Text] [Related]
16. [Is cystoscopy control necessary in patients surgically treated for tumors of the upper urinary tract?]. Kvist E; Bredesen J; Luke M; Lauritzen AF; Bille M Ugeskr Laeger; 1987 Jul; 149(31):2074-6. PubMed ID: 3433439 [No Abstract] [Full Text] [Related]
18. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy. Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876 [TBL] [Abstract][Full Text] [Related]
19. Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma. Tsui KH; Cheng AJ; Chang Pe; Pan TL; Yung BY Urology; 2004 Oct; 64(4):839-44. PubMed ID: 15491744 [TBL] [Abstract][Full Text] [Related]
20. [Transurethral surgical treatment of invasive bladder tumors (T1 and T2)]. Wolf H; Iversen HG; Olsen PR; Højgaard K; Schroeder T Ugeskr Laeger; 1987 Nov; 149(48):3247-50. PubMed ID: 3433525 [No Abstract] [Full Text] [Related] [Next] [New Search]